IL-13-Mediated gender difference in susceptibility to autoimmune encephalomyelitis

被引:41
作者
Sinha, Sushmita [1 ]
Kaler, Laurie J. [1 ]
Proctor, Thomas M. [1 ]
Teuscher, Cory [2 ,3 ]
Vandenbark, Arthur A. [1 ,4 ]
Offner, Halina [1 ,5 ]
机构
[1] Portland Med Affairs Med Ctr, Neuroimmunol Res R&D31, Portland, OR 97239 USA
[2] Univ Vermont, Dept Med, Burlington, VT 05405 USA
[3] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
[4] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA
[5] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA
关键词
D O I
10.4049/jimmunol.180.4.2679
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Females tend to have stronger Th1-mediated immune responses and are more prone to develop autoimmune diseases, including multiple sclerosis. Macrophages are major effector cells capable of mediating or modulating immune responses in experimental autoimmune encephalomyelitis (EAE). IL-13 and estrogen have opposing roles on macrophages (the former enhancing and the latter inhibiting) in terms of MHC class II (MHC II) up-regulation and, thus, these factors might influence susceptibility to EAE differently in females vs males. In accordance with this hypothesis, females lacking IL-13 displayed lower incidence and milder EAE disease severity than males after immunization with myelin oligodendrocyte glycoprotein (MOG)-35-55 peptide/CFA/pertussis toxin. Female IL-13 knockout (KO) mice with EAE consistently had reduced infiltration of CD11b(+) macrophages in the CNS along with significantly reduced expression of MHC H on these cells. Impaired MHC 11 expression was further corroborated upon LPS stimulation of female but not male bone marrow-derived CD11b(+) macrophages from IL-13KO mice, with restored expression after IL-13 pretreatment of female but not male macrophages. APCs from IIL-13KO females induced less proliferation by MOG-35-55-reactive T cells, and splenocytes from MOG peptide-immunized females had lower expression of IL-12, ILFN-gamma, MIP-2, and IFN-gamma-inducible protein 10 than males. In contrast, these splenocytes had higher expression of anti-inflammatory factors, IL-10, TGF-beta 1, and FoxP3, a cytokine pattern typical of regulatory type H monocytes. These data suggest that the difference in EAE susceptibility in females is strongly influenced by gender-specific proinflammatory effects of IL-13, mediated in part through up-regulation of Th1-inducing cytokines and MHC H on CD11b(+) macrophages.
引用
收藏
页码:2679 / 2685
页数:7
相关论文
共 37 条
[1]  
BAKER D, 1995, J IMMUNOL, V155, P4046
[2]   The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis [J].
Bauer, J ;
Huitinga, I ;
Zhao, WG ;
Lassmann, H ;
Hickey, WF ;
Dijkstra, CD .
GLIA, 1995, 15 (04) :437-446
[3]   Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis [J].
Benveniste, EN .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (03) :165-173
[4]  
BROSNAN CF, 1981, J IMMUNOL, V126, P614
[5]  
Butterfield RJ, 1998, J IMMUNOL, V161, P1860
[6]   Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis [J].
Butterfield, RJ ;
Blankenhorn, EP ;
Roper, RJ ;
Zachary, JF ;
Doerge, RW ;
Teuscher, G .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :637-645
[7]  
CASH E, 1994, J IMMUNOL, V153, P4258
[8]   IL-13 INDUCES PROLIFERATION AND DIFFERENTIATION OF HUMAN B-CELLS ACTIVATED BY THE CD40-LIGAND [J].
COCKS, BG ;
MALEFYT, RD ;
GALIZZI, JP ;
DEVRIES, JE ;
AVERSA, G .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :657-663
[9]   Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively [J].
Constantinescu, CS ;
Hilliard, B ;
Ventura, E ;
Wysocka, M ;
Showe, L ;
Lavi, E ;
Fujioka, T ;
Scott, P ;
Trinchieri, G ;
Rostami, A .
CLINICAL IMMUNOLOGY, 2001, 98 (01) :23-30
[10]  
Constantinescu CS, 1998, J IMMUNOL, V161, P5097